Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

I expect that several catalysts (including a LymPro partnership) will move the share price to the .25 range by September 1.

The company will announce a 1 for 20 reverse split and will move to the NASDAQ by November 1 with the share price in the $6.00 range.

It is imperative that the company up-lists as soon as possible because with the number of potential catalysts ahead the news of those events shouldn't be wasted because the company is a penny stock trading on the OTC market.

This is probably the best case scenario based on speculation regarding a number of potential catalyst that could realistically occur.

All the talks about the share price going to $2.00 and a reverse split not being needed is "hog wash".

All IMHO.

p.s. If you don't agree that is your choice. That is what makes a market.

Twitter: @AmarantusBio .... 9,964 followers.